These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8473325)

  • 1. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin.
    Kosfeld MD; Frazier WA
    J Biol Chem; 1993 Apr; 268(12):8808-14. PubMed ID: 8473325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1.
    Kosfeld MD; Frazier WA
    J Biol Chem; 1992 Aug; 267(23):16230-6. PubMed ID: 1644809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
    Prater CA; Plotkin J; Jaye D; Frazier WA
    J Cell Biol; 1991 Mar; 112(5):1031-40. PubMed ID: 1999454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.
    Guo NH; Krutzsch HC; Nègre E; Vogel T; Blake DA; Roberts DD
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3040-4. PubMed ID: 1557410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli.
    Kosfeld MD; Pavlopoulos TV; Frazier WA
    J Biol Chem; 1991 Dec; 266(36):24257-9. PubMed ID: 1761530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins.
    Gao AG; Frazier WA
    J Biol Chem; 1994 Nov; 269(47):29650-7. PubMed ID: 7525586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse mechanisms for cell attachment to platelet thrombospondin.
    Adams JC; Lawler J
    J Cell Sci; 1993 Apr; 104 ( Pt 4)():1061-71. PubMed ID: 8314891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis.
    Guo NH; Krutzsch HC; Nègre E; Zabrenetzky VS; Roberts DD
    J Biol Chem; 1992 Sep; 267(27):19349-55. PubMed ID: 1527055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein.
    Gao AG; Lindberg FP; Dimitry JM; Brown EJ; Frazier WA
    J Cell Biol; 1996 Oct; 135(2):533-44. PubMed ID: 8896608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.
    Tolsma SS; Volpert OV; Good DJ; Frazier WA; Polverini PJ; Bouck N
    J Cell Biol; 1993 Jul; 122(2):497-511. PubMed ID: 7686555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular attachment to thrombospondin. Cooperative interactions between receptor systems.
    Asch AS; Tepler J; Silbiger S; Nachman RL
    J Biol Chem; 1991 Jan; 266(3):1740-5. PubMed ID: 1703153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.
    Gao AG; Lindberg FP; Finn MB; Blystone SD; Brown EJ; Frazier WA
    J Biol Chem; 1996 Jan; 271(1):21-4. PubMed ID: 8550562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet thrombospondin mediates attachment and spreading of human melanoma cells.
    Roberts DD; Sherwood JA; Ginsburg V
    J Cell Biol; 1987 Jan; 104(1):131-9. PubMed ID: 3793757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoconjugates and cell adhesion: the adhesive proteins laminin, thrombospondin and von Willebrand's factor bind specifically to sulfated glycolipids.
    Ginsburg V; Roberts DD
    Biochimie; 1988 Nov; 70(11):1651-9. PubMed ID: 3149529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
    Clezardin P; Lawler J; Amiral J; Quentin G; Delmas P
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide.
    Zabrenetzky VS; Kohn EC; Roberts DD
    Cancer Res; 1990 Sep; 50(18):5937-42. PubMed ID: 2393863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
    Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
    J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
    Adams JC; Lawler J
    Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36.
    Li WX; Howard RJ; Leung LL
    J Biol Chem; 1993 Aug; 268(22):16179-84. PubMed ID: 7688364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins.
    Tuszynski GP; Rothman VL; Deutch AH; Hamilton BK; Eyal J
    J Cell Biol; 1992 Jan; 116(1):209-17. PubMed ID: 1730745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.